FDA Approves Gene Therapy with ISCRM Origins
July 5, 2023 | Categories: Core Faculty, Research |The FDA has approved a first-ever gene therapy for Duchenne muscular dystrophy based in part on technology developed by UW Medicine/ISCRM Researchers Read More
NIH Funds Collaborative Effort to Pinpoint the Origins of Duchenne Muscular Dystrophy
February 18, 2021 | Categories: Award, Core Faculty, Research |
Gene Therapy Cassettes Improved for Muscular Dystrophy
February 1, 2019 | Categories: Research |February 1, 2019 Experimental gene therapy cassettes for Duchenne muscular dystrophy have been modified to deliver better performance. The cassettes, which carry the therapy into muscle cells, contain newer versions […] Read More